Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD).

ABSTRACT:

SUBMITTER: Horita N 

PROVIDER: S-EPMC6464543 | biostudies-literature | 2017 Feb

REPOSITORIES: biostudies-literature